Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 Nov 2019
Historique:
received: 04 07 2019
revised: 21 08 2019
accepted: 23 08 2019
pubmed: 30 8 2019
medline: 23 5 2020
entrez: 30 8 2019
Statut: ppublish

Résumé

In the present study, we show that concomitant inhibition of Hedgehog (HH) signaling by the glioma-associated oncogene homolog1 (GLI1)-targeting agent GANT61 and the antiapoptotic BCL-2 protein family member MCL-1 by A-1210477 synergistically induces cell death in HH-driven cancers, i.e. rhabdomyosarcoma (RMS) and medulloblastoma (MB) cells. Combined genetic and pharmacological inhibition emphasized that co-treatment of GANT61 and A-1210477 indeed relies on inhibition of GLI1 (by GANT61) and MCL-1 (by A-1210477). Mechanistic studies revealed that A-1210477 triggers the release of BIM from MCL-1 and its shuttling to BCL-x

Identifiants

pubmed: 31465840
pii: S0304-3835(19)30449-5
doi: 10.1016/j.canlet.2019.08.012
pii:
doi:

Substances chimiques

A-1210477 0
GANT 61 0
GLI1 protein, human 0
Hedgehog Proteins 0
Indoles 0
MCL1 protein, human 0
Myeloid Cell Leukemia Sequence 1 Protein 0
Pyridines 0
Pyrimidines 0
Sulfonamides 0
Zinc Finger Protein GLI1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Michael Torsten Meister (MT)

Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, Goethe-University, Frankfurt, Germany.

Cathinka Boedicker (C)

Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

Benedikt Linder (B)

Experimental Neurosurgery, Neuroscience Center, Goethe-University Hospital, Frankfurt, Germany.

Donat Kögel (D)

German Cancer Consortium (DKTK), Partner Site Frankfurt, Germany; Experimental Neurosurgery, Neuroscience Center, Goethe-University Hospital, Frankfurt, Germany.

Thomas Klingebiel (T)

German Cancer Consortium (DKTK), Partner Site Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, Goethe-University, Frankfurt, Germany.

Simone Fulda (S)

Institute for Experimental Cancer Research in Pediatrics, Goethe-University Frankfurt, Komturstr. 3a, 60528, Frankfurt, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: simone.fulda@kgu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH